Navigating Medicare Changes in 2025: What to Expect Moving Forward

The Inflation Reduction Act (IRA) passed in 2022 included a number of changes to Medicare prescription drug plans, including some that will go into effect in early 2025. These changes impact the affordability of and access to coverage for millions of Americans, including people with HIV. Presenters from the ACE TA Center, in collaboration with the National Association of State & Territorial AIDS Directors (NASTAD), will provide an overview of changes impacting Medicare Part D enrollees, including the $2,000 cap on out-of-pocket costs and the upcoming implementation of the Medicare Prescription Payment Plan (MPPP). Presenters will also walk through considerations for Ryan White HIV/AIDS Program (RWHAP) recipients and subrecipients to ensure their clients understand these changes and how to access important new protections. Finally, presenters will discuss the impacts of the MPPP on revenue generation for RWHAP recipients.
By the end of the webinar, participants will be able to:
Describe upcoming policy changes to Medicare Part D for the 2025 plan year that will impact RWHAP clients
Articulate benefits and challenges associated with enrollment into the Medicare Prescription Payment Plan
Apply best practices to support RWHAP clients navigate major health coverage changes
This training webinar will be especially useful to RWHAP managers, case managers, and other staff that conduct outreach, benefits counseling, and enrollment activities, as well as the recipient and subrecipient staff that support these programs. RWHAP clients are also welcome to attend. Visit the ACE TA Center page at targethiv.org/ace to sign up for updates about new resources, download useful tools and resources, and register for upcoming webinars.